CHLN [China Housing & Land Development] CORRESP: (Original Filing)

[China Housing & Land Development, Inc. 1008 Liuxue Road, Baqiao District Xi’an, Shaanxi Province China 710038 March 12, 2014 VIA EDGAR Terence O’Brien Accounting Branch Chief Division of Corporation Finance 100 F Street, N.E RE: China Housing & Land Development, Inc. Form 10-K/A for Fiscal Year Ended December 31, 2012 Filed November 20, 2013 Response Letter Filed January 7, 2014]

CHLN [China Housing & Land Development] CORRESP: China Housing & Land Development, Inc. 1008 Liuxue

[China Housing & Land Development, Inc. 1008 Liuxue Road, Baqiao District Xi’an, Shaanxi Province China 710038 March 12, 2014 VIA EDGAR Terence O’Brien Accounting Branch Chief Division of Corporation Finance 100 F Street, N.E RE: China Housing & Land Development, Inc. Form 10-K/A for Fiscal Year Ended December 31, 2012 Filed November 20, 2013 Response Letter Filed January 7, 2014]

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE March 12, 2014 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2013 -- FY13 Total Sales Up 10.0% to $203.4 Million -- -- FY13 Operating Margin Up 240 Basis Points to 42.7% -- -- FY13 Non-GAAP Net Income Up 22.9% to $59.0 Million -- -- Issues FY14 Forecast -- BEIJING, China – March 12,] []

CBPO [China Biologic Products] 8-K: FOR RELEASE March 12, 2014 China Biologic Reports

[FOR RELEASE March 12, 2014 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2013 -- FY13 Total Sales Up 10.0% to $203.4 Million -- -- FY13 Operating Margin Up 240 Basis Points to 42.7% -- -- FY13 Non-GAAP Net Income Up 22.9% to $59.0 Million -- -- Issues FY14 Forecast -- BEIJING, China – March 12,] []

CBPO [China Biologic Products] 10-K: (Original Filing)

[] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Biologic Products, Inc.: We consent to the incorporation by reference in registration statements (No. 333-171069 and 333-182624) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 12, 2014, with respect to the consolidated balance sheets] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)]

CBPO [China Biologic Products] 10-K:

[] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Biologic Products, Inc.: We consent to the incorporation by reference in registration statements (No. 333-171069 and 333-182624) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 12, 2014, with respect to the consolidated balance sheets] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)]

UTSI [UTSTARCOM] 6-K: (Original Filing)

[UTStarcom Announces Share Subscription by Shah Capital Hong Kong, March 12, 2014 — UTStarcom (NASDAQ: UTSI), a global telecommunications infrastructure provider , today announced that it entered into a Share Subscription Agreement (the “ Subscription Agreement”) with Shah Capital Opportunity Fund LP (“Shah Capital”) on March 11, 2014. The transaction was consummated on the same date. Following the close of] [SHARE SUBSCRIPTION AGREEMENT This Share Subscription Agreement Agreement (this “ March 11 , 2014, is between Company Purchaser UTStarcom Holdings Corp., a company incorporated in the Cayman Islands (the “ WHEREAS, on the terms and conditions set forth in this Agreement, the Company desires to issue and allot to the Purchaser , and the Purchaser desire s to subscribe for] [FORM 6-K March 2014 UTSTARCOM HOLDINGS CORP. Union 7, Level 23, One Island East 18 Westlands Road, Hong Kong Form 20-F x Form 40-F o o o Yes o No x]

By | 2016-03-27T20:07:09+00:00 March 12th, 2014|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

UTSI [UTSTARCOM] 6-K: UTStarcom Announces Share Subscription by Shah Capital Hong

[UTStarcom Announces Share Subscription by Shah Capital Hong Kong, March 12, 2014 — UTStarcom (NASDAQ: UTSI), a global telecommunications infrastructure provider , today announced that it entered into a Share Subscription Agreement (the “ Subscription Agreement”) with Shah Capital Opportunity Fund LP (“Shah Capital”) on March 11, 2014. The transaction was consummated on the same date. Following the close of] [SHARE SUBSCRIPTION AGREEMENT This Share Subscription Agreement Agreement (this “ March 11 , 2014, is between Company Purchaser UTStarcom Holdings Corp., a company incorporated in the Cayman Islands (the “ WHEREAS, on the terms and conditions set forth in this Agreement, the Company desires to issue and allot to the Purchaser , and the Purchaser desire s to subscribe for] [FORM 6-K March 2014 UTSTARCOM HOLDINGS CORP. Union 7, Level 23, One Island East 18 Westlands Road, Hong Kong Form 20-F x Form 40-F o o o Yes o No x]

By | 2016-03-27T20:08:31+00:00 March 12th, 2014|Categories: Chinese Stocks, UTSI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar